Skip to main content
  • English (Ireland)
  • English
  • Greek (Greece)
  • Hungarian
  • Romanian
  • Slovenian
  • Spanish
  • Deutsch
  • Swedish
  • Danish
  • Dutch
  • Estonian
  • Latvian
  • French
  • Norwegian
  • Lithuanian
  • Czech
  • Slovak
  • Bulgarian
  • Portuguese (Portugal)
  • Greek (Cyprus)
  • German (Austria)
  • Dutch (Flemish (Belgium))
  • French (Belgium)
  • German Belgium
  • French (Luxembourg)
  • German Luxembourg
  • Icelandic
  • Croatian
  • Finnish
  • Italian
  • Polish
  • Home
  • SmPC

Imprint

Published by:

Bayer Ltd

Registered Office:

Bayer Limited

The Atrium

Blackthorn Road

Sandyford

Dublin 18

Tel: +353 1 216 3300

e-mail: info.ireland@bayerhealthcare.com

Company Registration Number: 16996

© Copyright Bayer Ltd

  • Privacy statement
  • Conditions of use
  • Imprint
  • Report a side effect
  • SmPC

© 2021 Bayer Ltd

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SmPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA.

PP-XAR-IE-0739-2

Last updated on 10/05/2021

Cookie consent image